The European Society of Cardiology (ESC) Congress took place in Munich, Germany, at the end of August 2004. One of the major events was the first presentation of the results of the ACTION trial. So, it is not surprising that the Bayer Healthcare conference booth focused on the exciting findings from ACTION.
To acknowledge the many delegates who visited the booth to discuss ACTION, we would like to share some impressions of these very successful days – including the booth, the press conference and the satellite symposium.
